Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125508711 | 12550871 | 1 | I | 20160505 | 20160523 | 20160712 | 20160712 | EXP | US-UCBSA-2016019358 | UCB | 51.90 | YR | F | Y | 0.00000 | 20160713 | PH | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125508711 | 12550871 | 1 | PS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | 400 MG, EV 4 WEEKS | U | U | 125160 | 400 | MG | SOLUTION FOR INJECTION | |||||
125508711 | 12550871 | 2 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | 400 MG, EV 2 WEEKS(QOW) | U | U | 125160 | 400 | MG | SOLUTION FOR INJECTION | QOW |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125508711 | 12550871 | 1 | Crohn's disease |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125508711 | 12550871 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125508711 | 12550871 | Arthralgia | |
125508711 | 12550871 | Fatigue | |
125508711 | 12550871 | Haematochezia | |
125508711 | 12550871 | Myalgia | |
125508711 | 12550871 | Pharyngitis streptococcal |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125508711 | 12550871 | 1 | 20150219 | 0 | ||
125508711 | 12550871 | 2 | 20160331 | 0 |